In This Section

AACR Cancer Centers Alliance

Basic and clinical cancer research discoveries stemming from the nation’s cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex disease, cancer in all its forms remains a major public health challenge that touches the lives of nearly every American, either directly or indirectly. The AACR Cancer Centers Alliance aims to accelerate the pace of discovery by providing an ongoing mechanism for transferring new knowledge, sharing resources, developing national demonstration projects, and driving innovation that impacts cancer science, cancer care delivery, and science and health policy.

The AACR Cancer Centers Alliance brings together these world-class institutions with the goal of facilitating collaboration and markedly expanding their scope and impact for the benefit of all patients. While a number of important areas of collaboration have been identified, the Alliance identified four main areas of focus and collaboration:

  • Basic and translational research
  • Clinical research, clinical trials, and regulatory science and policy
  • Education, training, and professional advancement
  • Artificial Intelligence and Data Science

By prioritizing collaborations that maximize synergies across cancer centers and that leverage each center’s unique strengths, the Alliance acts as a powerful force in accelerating the pace of cancer discovery, fostering health equity, and saving more lives from cancer.

About the Alliance

Join the Alliance

Directors of cancer centers who wish to join the AACR Cancer Centers Alliance should contact Yixian (John) Zhang, Vice President of Research and Grants Administration, at [email protected].

AACR Cancer Center Directors Alliance Steering Committee

David A. Tuveson, MD, PhD, FAACR

David A. Tuveson, MD, PhD, FAACR

Cold Spring Harbor Laboratory Cancer Center
Cold Spring Harbor, New York
Steering Committee Chair

Carlos L. Arteaga, MD, FAACR

Carlos L. Arteaga, MD, FAACR

Simmons Comprehensive Cancer Center at UT Southwestern Medical Center
Dallas, Texas

John L. Cleveland, PhD

John L. Cleveland, PhD

Moffitt Cancer Center
Tampa, Florida

Raymond N. DuBois, MD, PhD

Raymond N. DuBois, MD, PhD

MUSC Hollings Cancer Center
Charleston, South Carolina

Ruben A. Mesa, MD

Ruben A. Mesa, MD

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina

Karolina Palucka, MD, PhD

Karolina Palucka, MD, PhD

The Jackson Laboratory for Genomic Medicine
Farmington, Connecticut

Anil K. Rustgi, MD

Anil K. Rustgi, MD

Columbia University
New York, New York

Joann B. Sweasy, PhD

Joann B. Sweasy, PhD

Fred & Pamela Buffett Cancer Center
Omaha, Nebraska

Michael A. Teitell, MD, PhD

Michael A. Teitell, MD, PhD

UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California

Louis M. Weiner, MD

Louis M. Weiner, MD

Georgetown Lombardi Comprehensive Cancer Center
Washington, D.C.

Cheryl L. Willman, MD

Cheryl L. Willman, MD

Mayo Clinic Comprehensive Cancer Center
Rochester, Minnesota

Robert A. Winn, MD

Robert A. Winn, MD

Fox Chase Cancer Center
Philadelphia, PA

Matthew G. Vander Heiden, MD, PhD

Matthew G. Vander Heiden, MD, PhD

Koch Institute for Cancer Research at MIT
Cambridge, Massachusetts

Robert H. Vonderheide, MD

Robert H. Vonderheide, MD

Penn Medicine Abramson Cancer Center
Philadelphia, Pennsylvania